Inclisiran

Inclisiran for cholesterol: Docs call it expensive, bat for cheaper options

Even as India is set to soon launch promising new DCGI and US FDA-approved medicine Inclisiran to lower cholesterol and keep it low with just two doses a year, doctors, while hailing the advance, contend that the drug is expensive and stressed on better use of the much cheaper versions available. Jan 14, 2024
Ayodhya airport to follow 'drop-and-move' policy on Jan 22

Ayodhya airport to follow 'drop-and-move' policy on Jan 22

In view of the fact that the newly inaugurated Ayodhya airport will witness unprecedented rush on January 22 when the Pran Pratishtha ceremony takes place at the Ram temple, concerned officials have decided to adopt the 'drop-and-move' policy. Jan 11, 2024